CannBioRx Life Sciences Corp (ATNFW) — Financial Flexibility Index
CannBioRx Life Sciences Corp (ATNFW) has a Financial Flexibility Index of -0.21x as of June 2025. Free cash flow of $-1.13 Million (operating CF $-1.13 Million minus capex $4.00) represents 0% of total liabilities ($5.33 Million). Check ATNFW capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
CannBioRx Life Sciences Corp Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for CannBioRx Life Sciences Corp across 8 annual periods. For the full cash flow conversion analysis, see ATNFW operating cash flow.
Annual Financial Flexibility Index for CannBioRx Life Sciences Corp (2017–2024)
Year-by-year free cash flow to debt coverage for CannBioRx Life Sciences Corp. Explore CannBioRx Life Sciences Corp cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.42x | $-1.48 Million | $-1.48 Million | $3.51 Million | ▲ +79.2% |
| 2023 | -2.03x | $-10.92 Million | $-10.92 Million | $5.39 Million | ▼ -38.9% |
| 2022 | -1.46x | $-12.13 Million | $-12.13 Million | $8.31 Million | ▼ -782.0% |
| 2021 | -0.17x | $-3.87 Million | $-3.87 Million | $23.39 Million | ▼ -7.9% |
| 2020 | -0.15x | $-3.87 Million | $-3.87 Million | $25.25 Million | ▲ +35.7% |
| 2019 | -0.24x | $-3.17 Million | $-3.32 Million | $13.31 Million | ▼ -43.7% |
| 2018 | -0.17x | $-758.40K | $-789.23K | $4.57 Million | ▼ -41.2% |
| 2017 | -0.12x | $-497.36K | $-497.36K | $4.23 Million | — |